We are thrilled to announce our #SCDM2022 Keynote Speaker: Amy Abernethy. Join the President of Verily’s Clinical Studies Platforms on Monday, September 12 at 9:30 AM at one of the most awaited sessions of the SCDM 2022 Annual Conference, San Antonio, Texas.
The early bird discount ends on May 31. Register now and save!
Amy Abernethy is the President of Verily’s Clinical Studies Platforms, where she oversees the company’s clinical evidence generation platform product vision and related clinical research portfolio. Dr. Abernethy was most recently Principal Deputy Commissioner of Food and Drugs of the US Food and Drug Administration (FDA) and the agency’s acting Chief Information Officer.
Dr. Abernethy is a hematologist/oncologist and palliative medicine physician who has authored more than 500 publications.